ArticleJournal of clinical medicine2023

Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease.

Valentina Cossiga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.